|
TMEM218 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.554330E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.359300E-04 |
| Normal-vs-Stage2 |
6.423600E-02 |
| Normal-vs-Stage3 |
7.28079999956499E-07 |
| Normal-vs-Stage4 |
9.95759999999901E-05 |
| Stage1-vs-Stage2 |
2.743600E-01 |
| Stage1-vs-Stage3 |
1.299880E-02 |
| Stage1-vs-Stage4 |
7.689800E-02 |
| Stage2-vs-Stage3 |
4.695800E-03 |
| Stage2-vs-Stage4 |
1.407700E-02 |
| Stage3-vs-Stage4 |
8.813000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.399900E-04 |
| Normal-vs-AfricanAmerican |
7.959400E-04 |
| Normal-vs-Asian |
5.495300E-03 |
| Caucasian-vs-AfricanAmerican |
7.038000E-01 |
| Caucasian-vs-Asian |
2.274400E-01 |
| AfricanAmerican-vs-Asian |
2.760800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73063999999723E-05 |
| Normal-vs-Female |
3.011700E-02 |
| Male-vs-Female |
5.107900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.583000E-04 |
| Normal-vs-Extreme_Weight |
2.447400E-04 |
| Normal-vs-Obese |
2.278200E-03 |
| Normal-vs-Extreme_Obese |
1.104000E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.917000E-01 |
| Normal_Weight-vs-Obese |
3.927400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.672200E-01 |
| Extreme_Weight-vs-Obese |
3.422600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.080200E-01 |
| Obese-vs-Extreme_Obese |
1.603850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.295600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.224800E-03 |
| Normal-vs-Age(61-80Yrs) |
7.81840000000367E-05 |
| Normal-vs-Age(81-100Yrs) |
1.460100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.795400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.425800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.533430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.275430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.867900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.730800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.516200E-02 |
| Normal-VS-Type2 PRCC |
1.10840003841872E-09 |
| Normal-VS-KIRP CIMP |
4.812100E-04 |
| Normal-VS-Unclassified PRCC |
4.683000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.02099995125116E-09 |
| Type1 PRCC-VS-KIRP CIMP |
5.457600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.165440E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.099600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.076600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.302010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8967999999564E-06 |
| Normal-vs-N1 |
4.53940000000319E-06 |
| Normal-vs-N2 |
7.156100E-03 |
| N0-vs-N1 |
1.904210E-01 |
| N0-vs-N2 |
2.615800E-01 |
| N1-vs-N2 |
6.889200E-01 |
|
|
